Ampersand Biomedicines Acquires AbCheck to Accelerate Platform and Product Development
January 03, 2024 06:30 ET
|
Ampersand Biomedicines
BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today...